Cassano, N <br/><br/>
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease.  [electronic resource] 

 -  Journal of biological regulators and homeostatic agents   
 - 285-9 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0393-974X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents--immunology<br/>Antibodies--immunology<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Humanized<br/>Carrier State--immunology<br/>Drug Combinations<br/>Etanercept<br/>Female<br/>Hepatitis B--drug therapy<br/>Hepatitis B Surface Antigens--analysis<br/>Hepatitis B virus--physiology<br/>Humans<br/>Immunoglobulin G--immunology<br/>Infliximab<br/>Lamivudine--pharmacology<br/>Male<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor--immunology<br/>Retrospective Studies<br/>Reverse Transcriptase Inhibitors--pharmacology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Virus Latency--drug effects